Harald Carlsen

Harald Carlsen

Auto-generated profile, based on publicly available information

Harald Carlsen

Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2009 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
ADArnaud M. Didierlaurent
Arnaud M. Didierlaurent
SMSandra Morel
Sandra Morel
LLLaurence Lockman
Laurence Lockman
SGSandra L. Giannini
Sandra L. Giannini
MBMichel Bisteau
Michel Bisteau
NGNathalie Garçon
Nathalie Garçon
Adjuvant System 04 (AS04) combines the TLR4 agonist MPL (3-O-desacyl-4′-monophosphoryl lipid A) and aluminum salt. It is a new generation TLR-based adjuvant licensed for use in human vaccines. One of these vaccines, the human papillomavirus (HPV) vaccine Cervarix, is used in this study to elucidate the mechanism of action of AS04 in human cells and in mice. The adjuvant activity of AS04 was found to be strictly dependent on AS04 and the HPV Ags being injected at the same i.m. site within 24 h of each other. During this period, AS04 transiently induced local NF-κB activity and cytokine production. This led to an increased number of activated Ag-loaded dendritic cells and monocytes in the lymph node draining the injection site, which further increased the activation of Ag-specific T cells. AS04 was also found to directly stimulate those APCs in vitro but not directly stimulate CD4+ T or B lymphocytes. These AS04-induced innate responses were primarily due to MPL. Aluminum salt appeared not to synergize with or inhibit MPL, but rather it prolonged the cytokine responses to MPL at the injection site. Altogether these results support a model in which the addition of MPL to aluminum salt enhances the vaccine response by rapidly triggering a local cytokine response leading to an optimal activation of APCs. The transient and confined nature of these responses provides further supporting evidence for the favorable safety profile of AS04 adjuvanted vaccines.

16 March 2011 in Vaccine
Verified
Journal Article
Closed access
SMSandra Morel
Sandra Morel
ADArnaud Didierlaurent
Arnaud Didierlaurent
PBPatricia Bourguignon
Patricia Bourguignon
SDSophie Delhaye
Sophie Delhaye
BBBenoît Baras
Benoît Baras
MMMarcelle Van Mechelen
Marcelle Van Mechelen

1 January 2005 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
JMJan Ø Moskaug
Jan Ø Moskaug
HCHarald Carlsen
Harald Carlsen
MMMari Myhrstad
Mari Myhrstad
RBRune Blomhoff
Rune Blomhoff
Polyphenols in food plants are a versatile group of phytochemicals with many potentially beneficial activities in terms of disease prevention. In vitro cell culture experiments have shown that polyphenols possess antioxidant properties, and it is thought that these activities account for disease-preventing effects of diets high in polyphenols. However, polyphenols may be regarded as xenobiotics by animal cells and are to some extent treated as such, ie, they interact with phase I and phase II enzyme systems. We recently showed that dietary plant polyphenols, namely, the flavonoids, modulate expression of an important enzyme in both cellular antioxidant defenses and detoxification of xenobiotics, ie, γ-glutamylcysteine synthetase. This enzyme is rate limiting in the synthesis of the most important endogenous antioxidant in cells, glutathione. We showed in vitro that flavonoids increase expression of γ-glutamylcysteine synthetase and, by using a unique transgenic reporter mouse strain, we showed increased expression in vivo, with a concomitant increase in the intracellular glutathione concentrations in muscles. Because glutathione is important in redox regulation of transcription factors and enzymes for signal transduction, our results suggest that polyphenol-mediated regulation of glutathione alters cellular processes. Evidently, glutathione is important in many diseases, and regulation of intracellular glutathione concentrations may be one mechanism by which diet influences disease development. The aim of this review is to discuss some of the mechanisms involved in the glutathione-mediated, endogenous, cellular antioxidant defense system, how its possible modulation by dietary polyphenols such as flavonoids may influence disease development, and how it can be studied with in vivo imaging.

1 March 2002 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
MMMari Myhrstad
Mari Myhrstad
HCHarald Carlsen
Harald Carlsen
ONOlov Nordström
Olov Nordström
RBRune Blomhoff
Rune Blomhoff
JMJan Øivind Moskaug
Jan Øivind Moskaug

1 June 2004 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
ADArnaud Didierlaurent
Arnaud Didierlaurent
IFIsabel Ferrero
Isabel Ferrero
LOLuc A Otten
Luc A Otten
BDBertrand Dubois
Bertrand Dubois
MRMonique Reinhardt
Monique Reinhardt
JSJean-Claude Sirard
Jean-Claude Sirard
Activation of dendritic cells (DC) by microbial products via Toll-like receptors (TLR) is instrumental in the induction of immunity. In particular, TLR signaling plays a major role in the instruction of Th1 responses. The development of Th2 responses has been proposed to be independent of the adapter molecule myeloid differentiation factor 88 (MyD88) involved in signal transduction by TLRs. In this study we show that flagellin, the bacterial stimulus for TLR5, drives MyD88-dependent Th2-type immunity in mice. Flagellin promotes the secretion of IL-4 and IL-13 by Ag-specific CD4+ T cells as well as IgG1 responses. The Th2-biased responses are associated with the maturation of DCs, which are shown to express TLR5. Flagellin-mediated DC activation requires MyD88 and induces NF-κB-dependent transcription and the production of low levels of proinflammatory cytokines. In addition, the flagellin-specific response is characterized by the lack of secretion of the Th1-promoting cytokine IL-12 p70. In conclusion, this study suggests that flagellin and, more generally, TLR ligands can control Th2 responses in a MyD88-dependent manner.

1 November 2009 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
MZMustafa Zakkar
Mustafa Zakkar
KHKim Van der Heiden
Kim Van der Heiden
LLLe Anh Luong
Le Anh Luong
HCHera Chaudhury
Hera Chaudhury
SCSimon Cuhlmann
Simon Cuhlmann
Paul EvansPaul Evans
Paul Evans
Objective— Proinflammatory mediators influence atherosclerosis by inducing adhesion molecules (eg, VCAM-1) on endothelial cells (ECs) via signaling intermediaries including p38 MAP kinase. Regions of arteries exposed to high shear stress are protected from inflammation and atherosclerosis, whereas low-shear regions are susceptible. Here we investigated whether the transcription factor Nrf2 regulates EC activation in arteries. Methods and Results— En face staining revealed that Nrf2 was activated in ECs at an atheroprotected region of the murine aorta where it negatively regulated p38–VCAM-1 signaling, but was expressed in an inactive form in ECs at an atherosusceptible site. Treatment with sulforaphane, a dietary antioxidant, activated Nrf2 and suppressed p38–VCAM-1 signaling at the susceptible site in wild-type but not Nrf2 −/− animals, indicating that it suppresses EC activation via Nrf2. Studies of cultured ECs revealed that Nrf2 inactivates p38 by suppressing an upstream activator MKK3/6 and by enhancing the activity of the negative regulator MKP-1. Conclusions— Nrf2 prevents ECs at the atheroprotected site from exhibiting a proinflammatory state via the suppression of p38–VCAM-1 signaling. Pharmacological activation of Nrf2 reduces EC activation at atherosusceptible sites and may provide a novel therapeutic strategy to prevent or reduce atherosclerosis.